PATENT CLAIM ANALYSIS

Application Number: 15972518
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "456000"]

Abstract:
The present invention is directed to a class of anti-inflammatory, antioxidant nitroalkene compounds used in biological or biochemical applications to reduce oxidative stress or damage. The nitroalkene compounds described herein further avoid disadvantageous metabolism currently present in this field.

Claim (Index 18):
The method of treating an inflammation related disorder of  claim 15 , wherein the compound of Formula I is selected from the group consisting of:\n 2,5,7,8-tetramethyl-2-(2-nitrovinyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitropentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitro-2-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-2-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-3-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-3-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-4-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(5-nitro-4-pentenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitrooctenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitro-2-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-2-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-3-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-3-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-4-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(5-nitro-4-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(5-nitro-5-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(6-nitro-5-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(6-nitro-6-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(7-nitro-6-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(7-nitro-7-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(8-nitro-7-octenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitrotridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(2-nitro-2-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-2-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(3-nitro-3-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-3-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(4-nitro-4-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(5-nitro-4-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(5-nitro-5-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(6-nitro-5-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(6-nitro-6-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(7-nitro-6-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(7-nitro-7-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(8-nitro-7-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(8-nitro-8-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(9-nitro-8-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(9-nitro-9-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(10-nitro-9-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(10-nitro-10-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(11-nitro-10-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(11-nitro-11-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(12-nitro-11-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(12-nitro-12-tridecenyl)chroman-6-ol, 2,5,7,8-tetramethyl-2-(13-nitro-12-tridecenyl)chroman-6-ol, or a physiologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15244370', '12393836', '13245741', '15880628', '09937414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7820383592259146
- 35 USC 102 Novelty (BERT): 0.6305971437280304
- Combined Prediction Score: 0.7668942376761262
- Mean Citation Score: 339.222436
- Max Citation Score: 684.5693
- Similarity Product: 502.2995314083815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test